Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Troussard

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Cancer Epidemiology|October 17, 2017
Methodological issues of assessing the risk of a second cancer occurring in the same site as a first cancer using registry dataJérémie Jégu, Marie Moitry, Simona Bara, et al.
British Journal of Haematology|April 10, 2026
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life studyUrbain Tauveron-Jalenques, Luca Inchiappa, Jérôme Paillassa, et al.
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Preventive Medicine|July 3, 2016
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based studyFlorent Neumann, Jérémie Jégu, Christiane Mougin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based studyRoberta De Angelis, Pamela Minicozzi, Milena Sant, et al.
Cancers|February 26, 2025
Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based StudyStephane Kroudia Wasse, Emerline Assogba, Sebastien Orazio, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
British Journal of Haematology|February 1, 2011
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmFabrice Jardin, Philippe Ruminy, Francoise Parmentier, et al.
Cancer Epidemiology|January 24, 2017
Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivorsMarie Moitry, Michel Velten, Brigitte Trétarre, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2025
Corrigendum to "Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study" [Eur. J. Cancer 2025 Aug 26;226:115535. PMID: 40743655]Annalisa Trama, Silvia Rossi, Damien Bennet, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Cancer Epidemiology|October 17, 2017
Methodological issues of assessing the risk of a second cancer occurring in the same site as a first cancer using registry dataJérémie Jégu, Marie Moitry, Simona Bara, et al.
British Journal of Haematology|April 10, 2026
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life studyUrbain Tauveron-Jalenques, Luca Inchiappa, Jérôme Paillassa, et al.
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Preventive Medicine|July 3, 2016
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based studyFlorent Neumann, Jérémie Jégu, Christiane Mougin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based studyRoberta De Angelis, Pamela Minicozzi, Milena Sant, et al.
Cancers|February 26, 2025
Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based StudyStephane Kroudia Wasse, Emerline Assogba, Sebastien Orazio, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
British Journal of Haematology|February 1, 2011
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmFabrice Jardin, Philippe Ruminy, Francoise Parmentier, et al.
Cancer Epidemiology|January 24, 2017
Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivorsMarie Moitry, Michel Velten, Brigitte Trétarre, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2025
Corrigendum to "Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study" [Eur. J. Cancer 2025 Aug 26;226:115535. PMID: 40743655]Annalisa Trama, Silvia Rossi, Damien Bennet, et al.
Pageof 16